$PAHC
Phibro Animal Health Corp

2022 Q2 Form 10-K Financial Statement

#000155837022013940 Filed on August 24, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 2021 Q2
Revenue $255.3M $942.3M $220.3M
YoY Change 15.88% 13.07% 18.49%
Cost Of Revenue $176.8M $656.9M $150.5M
YoY Change 17.54% 16.88% 20.07%
Gross Profit $78.42M $285.4M $69.83M
YoY Change 12.31% 5.17% 15.23%
Gross Profit Margin 30.72% 30.29% 31.7%
Selling, General & Admin $55.54M $206.4M $50.67M
YoY Change 9.61% 5.04% 11.61%
% of Gross Profit 70.82% 72.32% 72.56%
Research & Development $20.83M
YoY Change 17.3%
% of Gross Profit 7.3%
Depreciation & Amortization $8.405M $32.71M $7.845M
YoY Change 7.14% 2.57% -3.86%
% of Gross Profit 10.72% 11.46% 11.23%
Operating Expenses $55.54M $227.2M $50.67M
YoY Change 9.61% 6.06% 11.36%
Operating Profit $22.89M $78.99M $19.16M
YoY Change 19.46% 5.5% 26.87%
Interest Expense -$10.52M $12.69M -$3.033M
YoY Change 246.75% -7.49% 59.63%
% of Operating Profit -45.95% 16.07% -15.83%
Other Income/Expense, Net
YoY Change
Pretax Income $12.37M $72.33M $16.13M
YoY Change -23.29% 8.81% -1.68%
Income Tax $4.882M $23.15M -$996.0K
% Of Pretax Income 39.47% 32.01% -6.18%
Net Earnings $7.487M $49.18M $17.12M
YoY Change -56.27% -9.58% 205.73%
Net Earnings / Revenue 2.93% 5.22% 7.77%
Basic Earnings Per Share $1.21
Diluted Earnings Per Share $184.8K $1.21 $422.7K
COMMON SHARES
Basic Shares Outstanding 40.50M
Diluted Shares Outstanding 40.50M

Balance Sheet

Concept 2022 Q2 2022 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $91.25M $91.25M $93.21M
YoY Change -2.11% -2.11% 2.09%
Cash & Equivalents $74.25M $74.25M $50.21M
Short-Term Investments $17.00M $17.00M $43.00M
Other Short-Term Assets $49.29M $49.29M $42.53M
YoY Change 15.88% 15.88% 13.99%
Inventory $259.2M $259.2M $216.3M
Prepaid Expenses
Receivables $166.5M $166.5M $146.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $566.2M $566.2M $498.9M
YoY Change 13.49% 13.49% 10.42%
LONG-TERM ASSETS
Property, Plant & Equipment $165.5M $203.2M $154.7M
YoY Change 6.97% 8.26% 4.45%
Goodwill $53.23M $52.68M
YoY Change 1.04% 0.0%
Intangibles
YoY Change
Long-Term Investments $4.362M $10.35M $4.141M
YoY Change 5.34% 2.38% -1.85%
Other Assets $82.89M $34.86M $72.75M
YoY Change 13.94% 17.46% 20.29%
Total Long-Term Assets $365.5M $365.5M $342.4M
YoY Change 6.73% 6.73% 3.06%
TOTAL ASSETS
Total Short-Term Assets $566.2M $566.2M $498.9M
Total Long-Term Assets $365.5M $365.5M $342.4M
Total Assets $931.7M $931.7M $841.3M
YoY Change 10.74% 10.74% 7.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $95.60M $95.60M $68.36M
YoY Change 39.84% 39.84% 3.44%
Accrued Expenses $47.45M $47.45M $86.38M
YoY Change -45.06% -1.76% 19.31%
Deferred Revenue $822.0K $1.560M
YoY Change -47.31% 40.67%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $15.00M $15.00M $9.375M
YoY Change 60.0% 60.0% -50.13%
Total Short-Term Liabilities $190.8M $190.8M $164.1M
YoY Change 16.28% 16.28% 4.37%
LONG-TERM LIABILITIES
Long-Term Debt $417.9M $417.9M $382.7M
YoY Change 9.2% 9.2% 3.91%
Other Long-Term Liabilities $60.50M $51.24M $55.97M
YoY Change 8.09% 3.88% -20.5%
Total Long-Term Liabilities $60.50M $469.2M $55.97M
YoY Change 8.09% 8.59% -20.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $190.8M $190.8M $164.1M
Total Long-Term Liabilities $60.50M $469.2M $55.97M
Total Liabilities $669.3M $669.3M $602.8M
YoY Change 11.03% 11.03% 1.16%
SHAREHOLDERS EQUITY
Retained Earnings $247.7M $218.0M
YoY Change 13.64% 19.09%
Common Stock $135.8M $135.8M
YoY Change 0.0% 0.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $262.4M $262.4M $238.5M
YoY Change
Total Liabilities & Shareholders Equity $931.7M $931.7M $841.3M
YoY Change 10.74% 10.74% 7.3%

Cashflow Statement

Concept 2022 Q2 2022 2021 Q2
OPERATING ACTIVITIES
Net Income $7.487M $49.18M $17.12M
YoY Change -56.27% -9.58% 205.73%
Depreciation, Depletion And Amortization $8.405M $32.71M $7.845M
YoY Change 7.14% 2.57% -3.86%
Cash From Operating Activities $1.574M $31.65M $3.066M
YoY Change -48.66% -34.48% -20.98%
INVESTING ACTIVITIES
Capital Expenditures -$11.89M -$37.04M -$7.090M
YoY Change 67.7% 26.34% -29.66%
Acquisitions $13.51M
YoY Change
Other Investing Activities $2.350M -$620.0K -$100.0K
YoY Change -2450.0% -149.21% -118.52%
Cash From Investing Activities -$9.540M -$22.58M -$7.190M
YoY Change 32.68% 21.54% -24.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.39M 16.34M 4.635M
YoY Change 167.29% -196.16% -69.08%
NET CHANGE
Cash From Operating Activities 1.574M 31.65M 3.066M
Cash From Investing Activities -9.540M -22.58M -7.190M
Cash From Financing Activities 12.39M 16.34M 4.635M
Net Change In Cash 4.423M 24.04M 511.0K
YoY Change 765.56% 73.31% -94.53%
FREE CASH FLOW
Cash From Operating Activities $1.574M $31.65M $3.066M
Capital Expenditures -$11.89M -$37.04M -$7.090M
Free Cash Flow $13.46M $68.69M $10.16M
YoY Change 32.57% -11.51% -27.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Auditor Firm
AuditorFirmId
238
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
6107000
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3486000
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4840000
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
55512000
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
3643000
CY2021Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
264000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3510000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
49175000
CY2022 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
54385000
CY2020 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Interest Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
33552000
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2021 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Interest Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2021Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
735000
CY2022 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Interest Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2020 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Expected Return Loss Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2021 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Expected Return Loss Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2022 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Expected Return Loss Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 us-gaap Defined Benefit Plan Type Extensible List
DefinedBenefitPlanTypeExtensibleList
http://fasb.org/us-gaap/2022#PensionPlansDefinedBenefitMember
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q2 us-gaap Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07666-6712
CY2022Q2 us-gaap Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022 dei City Area Code
CityAreaCode
201
CY2022 dei Local Phone Number
LocalPhoneNumber
329-7300
CY2021 us-gaap Defined Benefit Plan Type Extensible List
DefinedBenefitPlanTypeExtensibleList
http://fasb.org/us-gaap/2022#PensionPlansDefinedBenefitMember
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Teaneck
CY2022 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001
CY2022 dei Trading Symbol
TradingSymbol
PAHC
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 us-gaap Defined Benefit Plan Type Extensible List
DefinedBenefitPlanTypeExtensibleList
http://fasb.org/us-gaap/2022#PensionPlansDefinedBenefitMember
CY2020 us-gaap Defined Contribution Plan Sponsor Location Extensible List
DefinedContributionPlanSponsorLocationExtensibleList
http://xbrl.sec.gov/country/2022#US
CY2021 us-gaap Defined Contribution Plan Sponsor Location Extensible List
DefinedContributionPlanSponsorLocationExtensibleList
http://xbrl.sec.gov/country/2022#US
CY2022 us-gaap Defined Contribution Plan Sponsor Location Extensible List
DefinedContributionPlanSponsorLocationExtensibleList
http://xbrl.sec.gov/country/2022#US
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001069899
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.pahc.com/20220630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.pahc.com/20220630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2021Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2020 us-gaap Defined Benefit Plan Sponsor Location Extensible List
DefinedBenefitPlanSponsorLocationExtensibleList
http://xbrl.sec.gov/country/2022#US
CY2021 us-gaap Defined Benefit Plan Sponsor Location Extensible List
DefinedBenefitPlanSponsorLocationExtensibleList
http://xbrl.sec.gov/country/2022#US
CY2022 us-gaap Defined Benefit Plan Sponsor Location Extensible List
DefinedBenefitPlanSponsorLocationExtensibleList
http://xbrl.sec.gov/country/2022#US
CY2020 us-gaap Defined Benefit Plan Funding Status Extensible List
DefinedBenefitPlanFundingStatusExtensibleList
http://fasb.org/us-gaap/2022#FundedPlanMember
CY2021 us-gaap Defined Benefit Plan Funding Status Extensible List
DefinedBenefitPlanFundingStatusExtensibleList
http://fasb.org/us-gaap/2022#FundedPlanMember
CY2022 us-gaap Defined Benefit Plan Funding Status Extensible List
DefinedBenefitPlanFundingStatusExtensibleList
http://fasb.org/us-gaap/2022#FundedPlanMember
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2021Q2 us-gaap Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://www.pahc.com/20220630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q2 us-gaap Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://www.pahc.com/20220630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2021Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.pahc.com/20220630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.pahc.com/20220630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2021Q2 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://www.pahc.com/20220630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q2 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://www.pahc.com/20220630#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-36410
CY2022 dei Entity Registrant Name
EntityRegistrantName
Phibro Animal Health Corporation
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1840497
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
Glenpointe Centre East, 3rd Floor
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
300 Frank W. Burr Boulevard, Suite 21
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Public Float
EntityPublicFloat
414078679
CY2022 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2022 dei Auditor Location
AuditorLocation
Florham Park, New Jersey
CY2020 us-gaap Net Income Loss
NetIncomeLoss
33552000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-32513000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
942261000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
833350000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
800354000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
656861000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
561973000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
543472000
CY2022 us-gaap Gross Profit
GrossProfit
285400000
CY2021 us-gaap Gross Profit
GrossProfit
271377000
CY2020 us-gaap Gross Profit
GrossProfit
256882000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
206414000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
196509000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
187688000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
78986000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
74868000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
69194000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-11875000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12880000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12856000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5216000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4480000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-826000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
72327000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66468000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
55512000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23152000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12083000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21960000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
49175000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
54385000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
33552000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.21
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.34
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.21
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40473000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
49175000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
54385000
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
21681000
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
12658000
CY2021Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
95000000
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
272925000
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
4235000
CY2022Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1174000
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-12854000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-18939000
CY2022Q2 us-gaap Liabilities
Liabilities
669257000
CY2021Q2 us-gaap Liabilities
Liabilities
602796000
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-2598000
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
2521000
CY2022 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
4327000
CY2021 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
3807000
CY2020 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-3684000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5820000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15092000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-44204000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43355000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
69477000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10652000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74248000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50212000
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
17000000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
43000000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
166537000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
146852000
CY2022Q2 us-gaap Inventory Net
InventoryNet
259158000
CY2021Q2 us-gaap Inventory Net
InventoryNet
216312000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
49289000
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
42533000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
566232000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
498909000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
165490000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
154706000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63861000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62282000
CY2022Q2 us-gaap Goodwill
Goodwill
53226000
CY2021Q2 us-gaap Goodwill
Goodwill
52679000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82890000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72749000
CY2022Q2 us-gaap Assets
Assets
931699000
CY2021Q2 us-gaap Assets
Assets
841325000
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
15000000
CY2021Q2 us-gaap Loans Payable Current
LoansPayableCurrent
9375000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
95596000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
68362000
CY2022Q2 pahc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
80236000
CY2021Q2 pahc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
86379000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
190832000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
164116000
CY2022Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
145000000
CY2021Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
287710000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
60500000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55970000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18209000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-28713000
CY2021Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1176000
CY2022Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
46999000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1721000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1898000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
135803000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
135803000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
247748000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
218015000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-121113000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115293000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
262442000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
238529000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
931699000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
841325000
CY2022 us-gaap Profit Loss
ProfitLoss
49175000
CY2021 us-gaap Profit Loss
ProfitLoss
54385000
CY2020 us-gaap Profit Loss
ProfitLoss
33552000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32705000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31885000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32341000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
590000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
833000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
882000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1129000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2259000
CY2022 pahc Acquisition Related Items
AcquisitionRelatedItems
316000
CY2020 pahc Acquisition Related Items
AcquisitionRelatedItems
-2433000
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-806000
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2183000
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
8125000
CY2022 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1203000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4808000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
9718000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
2540000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-319000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1844000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-818000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23625000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12498000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12930000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1804000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1631000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11137000
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
297000000
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
317500000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2121000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
26358000
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
243000000
CY2022 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
247000000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13869000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3176000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7672000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3152000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1191000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-8509000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31649000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
48306000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59348000
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
64100000
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
74000000
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
80000000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
90100000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
86000000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
49000000
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
37044000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
29320000
CY2020 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
34045000
CY2022 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
13511000
CY2020 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
54549000
CY2022 us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
1353000
CY2022 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-620000
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1260000
CY2020 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
796000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22582000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18580000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-120390000
CY2021 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
391500000
CY2020 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
170000000
CY2021 pahc Proceeds From Issuance Of Long Term Debt Long Term Loans Payable
ProceedsFromIssuanceOfLongTermDebtLongTermLoansPayable
300000000
CY2022 pahc Repayments Of Long Term Debt Long Term Loans Payable And Other
RepaymentsOfLongTermDebtLongTermLoansPayableAndOther
9375000
CY2021 pahc Repayments Of Long Term Debt Long Term Loans Payable And Other
RepaymentsOfLongTermDebtLongTermLoansPayableAndOther
220625000
CY2020 pahc Repayments Of Long Term Debt Long Term Loans Payable And Other
RepaymentsOfLongTermDebtLongTermLoansPayableAndOther
12646000
CY2022 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4840000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2940000
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19442000
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19430000
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19418000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16343000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16995000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40936000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1374000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1138000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1124000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24036000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43355000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21230000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50212000
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19442000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36343000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57573000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74248000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50212000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36343000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
11159000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
10808000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
11577000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17854000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19395000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
20866000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2953000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2957000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4353000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
216015000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10652000
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19418000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2259000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
188204000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
69477000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19430000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1129000
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-851000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
238529000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
262442000
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 6pt 0pt;">1.     Description of Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food and companion animals including poultry, swine, dairy and beef cattle, aquaculture and dogs. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.</p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 6pt 0pt;">Risks and Uncertainties </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">The COVID-19 pandemic continues to directly or indirectly impact our business, results of operations and financial condition. New information may continue to emerge concerning COVID-19, and the actions required to contain or treat it may affect the duration and severity of the pandemic. The pandemic may continue to have significant economic impacts on customers, suppliers and markets. The pandemic could affect our future revenues, expenses, reserves and allowances, manufacturing operations and employee-related costs. Our financial statements include estimates of the effects of COVID-19 and there may be changes to those estimates in future periods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">The issue of the potential for increased bacterial resistance to certain antibiotics used in certain food-producing animals is the subject of discussions on a worldwide basis and, in certain instances, has led to government restrictions on or banning of the use of antibiotics in food-producing animals. The sale of antibiotics and antibacterials is a material portion of our business. Should product bans or restrictions, public perception, competition or other developments result in restrictions on the sale of such products, it could have a material adverse effect on our financial position, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">An outbreak of disease carried by food animals, which could lead to the widespread death or precautionary destruction of food animals as well as reduced consumption and demand for animal protein, could adversely affect demand for our products. Such occurrences could have a material adverse effect on our financial condition, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">The testing, manufacturing, and marketing of certain of our products are subject to extensive regulation by numerous government authorities in the United States and other countries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 6pt 0pt;">We have significant assets in Israel, Brazil and other locations outside of the United States and a significant portion of our sales and earnings are attributable to operations conducted abroad. Our assets, results of operations and future prospects are subject to currency exchange fluctuations and restrictions, energy shortages, other economic developments, political or social instability in some countries, and uncertainty of, and governmental control over, commercial rights, which could result in a material adverse effect on our financial position, results of operations and cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">We are subject to environmental laws and regulations governing the use, storage, handling, generation, treatment, emission, release, discharge and disposal of certain materials and wastes, the remediation of contaminated soil and groundwater, the manufacture, sale and use of regulated materials, including pesticides, and the health and safety of </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">employees. As such, the nature of our current and former operations and those of our subsidiaries expose Phibro and our subsidiaries to the risk of claims with respect to such matters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:6pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">Our business could be impacted by economic sanctions, bans, boycotts, or broader military conflicts that result from the armed conflict between Russia and Ukraine. Other potential impacts include supply chain and logistics disruptions, macroeconomic impacts from the exclusion of Russian financial institutions from the global banking system, volatility in foreign exchange rates and interest rates, inflationary pressures on raw materials and energy, as well as heightened cybersecurity threats. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><span style="margin-bottom:6pt;visibility:hidden;">​</span></p>
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.21
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
942261000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
833350000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.34
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
800354000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 6pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The Company’s consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP). Preparation of these financial statements requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. Actual results could differ from these estimates. Estimates are used when accounting for the valuation of intangible assets, depreciation and amortization periods of long-lived and intangible assets, recoverability of long-lived and intangible assets and goodwill, realizability of deferred income tax assets, sales discounts, rebates, allowances and incentives, contingencies, employee compensation and actuarial assumptions related to our pension plans. We regularly evaluate our estimates and assumptions using historical experience and other factors. Our estimates are based on complex judgments, probabilities and assumptions that we believe to be reasonable.</p>
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.21
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
942261000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.83
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
833350000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49175000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
54385000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
33552000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40473000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40454000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
31000
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
50000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3807000
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
800354000
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2051000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3674000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
822000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1560000
CY2022 pahc Payment Term Low End Of Range
PaymentTermLowEndOfRange
P30D
CY2022 pahc Payment Term High End Of Range
PaymentTermHighEndOfRange
P120D
CY2022 pahc Average Customer Collection Period High End Of Range
AverageCustomerCollectionPeriodHighEndOfRange
P60D
CY2022 pahc Average Customer Collection Period Low End Of Range
AverageCustomerCollectionPeriodLowEndOfRange
P6D
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
183000
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1038000
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
265000
CY2020 us-gaap Interest Expense Other
InterestExpenseOther
663000
CY2022 us-gaap Interest Expense
InterestExpense
12691000
CY2021 us-gaap Interest Expense
InterestExpense
13718000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
105000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
590000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
833000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
882000
CY2021 pahc Debt Instrument Refinancing Costs
DebtInstrumentRefinancingCosts
1020000
CY2020 us-gaap Interest Expense
InterestExpense
14613000
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
816000
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
838000
CY2020 us-gaap Interest And Other Income
InterestAndOtherIncome
1757000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-11875000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-12880000
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-12856000
CY2022 us-gaap Depreciation
Depreciation
23781000
CY2021 us-gaap Depreciation
Depreciation
23165000
CY2020 us-gaap Depreciation
Depreciation
23250000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8924000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8715000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8869000
CY2021 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
5000
CY2020 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
222000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32705000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31885000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32341000
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1047000
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1254000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18904000
CY2020Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.028
CY2022 pahc Allowance For Doubtful Accounts Receivable Effect Of Changes In Exchange Rates
AllowanceForDoubtfulAccountsReceivableEffectOfChangesInExchangeRates
-372000
CY2021 pahc Allowance For Doubtful Accounts Receivable Effect Of Changes In Exchange Rates
AllowanceForDoubtfulAccountsReceivableEffectOfChangesInExchangeRates
26000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
180000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9614000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9375000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
7769000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
6805000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
6556000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
23742000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63861000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17350000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20832000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17759000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13738000
CY2022Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
170047000
CY2021Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
150659000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3510000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3807000
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
166537000
CY2021Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
146852000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3807000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3940000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
255000
CY2021Q2 us-gaap Inventory Net
InventoryNet
216312000
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
87030000
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
59775000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
15468000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12738000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
156660000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
143799000
CY2022Q2 us-gaap Inventory Net
InventoryNet
259158000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
406455000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
377757000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
240965000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
223051000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
165490000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
154706000
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4320000
CY2021Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4236000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
148189000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
137870000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
84328000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
75588000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63861000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62282000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35375000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6051000
CY2021Q2 us-gaap Goodwill
Goodwill
52679000
CY2020Q2 us-gaap Goodwill
Goodwill
52679000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
561000
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-14000
CY2022Q2 us-gaap Goodwill
Goodwill
53226000
CY2021Q2 us-gaap Goodwill
Goodwill
52679000
CY2022Q2 pahc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
80236000
CY2021Q2 pahc Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
86379000
CY2022Q2 pahc Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
7639000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37680000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32962000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5849000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9861000
CY2022Q2 us-gaap Deposits Assets
DepositsAssets
5905000
CY2021Q2 us-gaap Deposits Assets
DepositsAssets
5663000
CY2022Q2 pahc Insurance Investment
InsuranceInvestment
5984000
CY2021Q2 pahc Insurance Investment
InsuranceInvestment
5964000
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
4362000
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
4141000
CY2022Q2 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
12976000
CY2021Q2 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
2696000
CY2021Q2 pahc Pension And Other Postretirement And Postemployment Benefit Plans Assets Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansAssetsNoncurrent
1184000
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1436000
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1811000
CY2022Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
8698000
CY2021Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
8467000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82890000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72749000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34278000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6618000
CY2022Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7125000
CY2021Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
6312000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5493000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4380000
CY2022Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
7211000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31508000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28003000
CY2022Q2 pahc Long Term And Deferred Income Taxes
LongTermAndDeferredIncomeTaxes
9264000
CY2021Q2 pahc Long Term And Deferred Income Taxes
LongTermAndDeferredIncomeTaxes
6646000
CY2022Q2 pahc Other Employee Related Liabilities Supplemental Retirement Benefits Deferred Compensation And Other Noncurrent
OtherEmployeeRelatedLiabilitiesSupplementalRetirementBenefitsDeferredCompensationAndOtherNoncurrent
7368000
CY2021Q2 pahc Other Employee Related Liabilities Supplemental Retirement Benefits Deferred Compensation And Other Noncurrent
OtherEmployeeRelatedLiabilitiesSupplementalRetirementBenefitsDeferredCompensationAndOtherNoncurrent
8382000
CY2022Q2 pahc Other Employee Related Liabilities Domestic Pension Plans Noncurrent
OtherEmployeeRelatedLiabilitiesDomesticPensionPlansNoncurrent
1793000
CY2022Q2 pahc Other Employee Related Liabilities International Retirement Plans Noncurrent
OtherEmployeeRelatedLiabilitiesInternationalRetirementPlansNoncurrent
4620000
CY2021Q2 pahc Other Employee Related Liabilities International Retirement Plans Noncurrent
OtherEmployeeRelatedLiabilitiesInternationalRetirementPlansNoncurrent
5345000
CY2022Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
5947000
CY2021Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
7594000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
60500000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55970000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-121113000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115293000
CY2022Q2 pahc Long Term Debt Gross Maturity Year One
LongTermDebtGrossMaturityYearOne
15000000
CY2022Q2 pahc Long Term Debt Maturity Interest Payments Year One
LongTermDebtMaturityInterestPaymentsYearOne
11806000
CY2022Q2 pahc Long Term Debt Gross Maturity Year Two
LongTermDebtGrossMaturityYearTwo
16875000
CY2022Q2 pahc Long Term Debt Maturity Interest Payments Year Two
LongTermDebtMaturityInterestPaymentsYearTwo
11287000
CY2022Q2 pahc Long Term Debt Gross Maturity Year Three
LongTermDebtGrossMaturityYearThree
24375000
CY2022Q2 pahc Long Term Debt Maturity Interest Payments Year Three
LongTermDebtMaturityInterestPaymentsYearThree
10605000
CY2022Q2 pahc Long Term Debt Gross Maturity Year Four
LongTermDebtGrossMaturityYearFour
377500000
CY2022Q2 pahc Long Term Debt Maturity Interest Payments Year Four
LongTermDebtMaturityInterestPaymentsYearFour
10844000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
433750000
CY2022Q2 pahc Long Term Debt Maturity Interest Payments
LongTermDebtMaturityInterestPayments
44542000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
37680000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32962000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6051000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6618000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31508000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28003000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
37559000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
34621000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
8461000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
7989000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
1376000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
1176000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1214000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
873000
CY2022 us-gaap Lease Cost
LeaseCost
11051000
CY2021 us-gaap Lease Cost
LeaseCost
10038000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
8642000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
8292000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11930000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
16665000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y5M15D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y5M1D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0366
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0404
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7169000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5895000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4556000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3413000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2981000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
22129000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
46143000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8584000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
37559000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
0
CY2022 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
0
CY2022 pahc Minimum Common Stock Ownership Conversion Threshold
MinimumCommonStockOwnershipConversionThreshold
0.15
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19442000
CY2008Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
6630000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5081620
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2022Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
4022000
CY2022Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
21002000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4874000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
99000
CY2021 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.022
CY2020 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.022
CY2021Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
77915000
CY2020Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
79353000
CY2022 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1675000
CY2021 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1682000
CY2022 us-gaap Defined Benefit Plan Benefit Obligation Benefits Paid
DefinedBenefitPlanBenefitObligationBenefitsPaid
2426000
CY2021 us-gaap Defined Benefit Plan Benefit Obligation Benefits Paid
DefinedBenefitPlanBenefitObligationBenefitsPaid
2260000
CY2022 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-14085000
CY2021 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-860000
CY2022Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
63079000
CY2021Q2 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
77915000
CY2021Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
79099000
CY2020Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
75791000
CY2022 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
-15387000
CY2021 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
4838000
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
730000
CY2022 us-gaap Defined Benefit Plan Plan Assets Benefits Paid
DefinedBenefitPlanPlanAssetsBenefitsPaid
2426000
CY2021 us-gaap Defined Benefit Plan Plan Assets Benefits Paid
DefinedBenefitPlanPlanAssetsBenefitsPaid
2260000
CY2022Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
61286000
CY2021Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
79099000
CY2022Q2 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-1793000
CY2021Q2 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
1184000
CY2022 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.044
CY2021 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.044
CY2020 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.049
CY2022Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.046
CY2021Q2 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.029
CY2021Q2 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
-19973000
CY2020Q2 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
-22571000
CY2022 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
480000
CY2021 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Before Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
560000
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Cost Credit Arising During Period Before Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
-4715000
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Cost Credit Arising During Period Before Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
2038000
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
4235000
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-2598000
CY2022Q2 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
-24208000
CY2021Q2 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Before Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
-19973000
CY2022 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1675000
CY2021 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1682000
CY2020 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2112000
CY2022 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3413000
CY2021 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3660000
CY2020 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3144000
CY2022 pahc Defined Benefit Plan Amortization Of Actuarial Gain Loss Immediate Recognition As Component In Net Periodic Benefit Cost Credit And Amortization Of Prior Service Costs
DefinedBenefitPlanAmortizationOfActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCreditAndAmortizationOfPriorServiceCosts
480000
CY2021 pahc Defined Benefit Plan Amortization Of Actuarial Gain Loss Immediate Recognition As Component In Net Periodic Benefit Cost Credit And Amortization Of Prior Service Costs
DefinedBenefitPlanAmortizationOfActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCreditAndAmortizationOfPriorServiceCosts
560000
CY2020 pahc Defined Benefit Plan Amortization Of Actuarial Gain Loss Immediate Recognition As Component In Net Periodic Benefit Cost Credit And Amortization Of Prior Service Costs
DefinedBenefitPlanAmortizationOfActuarialGainLossImmediateRecognitionAsComponentInNetPeriodicBenefitCostCreditAndAmortizationOfPriorServiceCosts
515000
CY2022 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-1258000
CY2021 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-1418000
CY2020 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-517000
CY2022 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.022
CY2022 pahc Minimum Par Value Required For Corporate Bond To Determine Discount Rate
MinimumParValueRequiredForCorporateBondToDetermineDiscountRate
250000000
CY2022Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
3398000
CY2022Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
3606000
CY2022Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
3758000
CY2022Q2 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
3883000
CY2021Q2 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
79099000
CY2022Q2 pahc Defined Benefit Plan Cash And Cash Equivalents Measurement Input Price Per Unit
DefinedBenefitPlanCashAndCashEquivalentsMeasurementInputPricePerUnit
1
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.060
CY2022 pahc Defined Contribution Plan Employer Discretionary Contribution Percent
DefinedContributionPlanEmployerDiscretionaryContributionPercent
0.045
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6341000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5803000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5566000
CY2022Q2 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
12088000
CY2021Q2 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
13827000
CY2022 pahc Other Employee Benefit Plans Expense International Retirement Plans Supplemental Retirement Benefits And Long Term Incentive Arrangements
OtherEmployeeBenefitPlansExpenseInternationalRetirementPlansSupplementalRetirementBenefitsAndLongTermIncentiveArrangements
3788000
CY2021 pahc Other Employee Benefit Plans Expense International Retirement Plans Supplemental Retirement Benefits And Long Term Incentive Arrangements
OtherEmployeeBenefitPlansExpenseInternationalRetirementPlansSupplementalRetirementBenefitsAndLongTermIncentiveArrangements
5095000
CY2020 pahc Other Employee Benefit Plans Expense International Retirement Plans Supplemental Retirement Benefits And Long Term Incentive Arrangements
OtherEmployeeBenefitPlansExpenseInternationalRetirementPlansSupplementalRetirementBenefitsAndLongTermIncentiveArrangements
5725000
CY2021Q2 pahc Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
8312000
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-1066000
CY2021Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4672000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
27695000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
12684000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-3142000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
44632000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
53784000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
58654000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
72327000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66468000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1271000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1468000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
887000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
401000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
17613000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
13280000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
14705000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
23955000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14266000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
13835000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-75000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
291000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
5226000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
251000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-110000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
696000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
23000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2663000
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
218000
CY2022 pahc Deferred Foreign Income Tax Expense Benefit Change In Valuation Allowance
DeferredForeignIncomeTaxExpenseBenefitChangeInValuationAllowance
-1002000
CY2021 pahc Deferred Foreign Income Tax Expense Benefit Change In Valuation Allowance
DeferredForeignIncomeTaxExpenseBenefitChangeInValuationAllowance
299000
CY2020 pahc Deferred Foreign Income Tax Expense Benefit Change In Valuation Allowance
DeferredForeignIncomeTaxExpenseBenefitChangeInValuationAllowance
1985000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-803000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2183000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8125000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23152000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12083000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21960000
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22162000
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
29219000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2618000
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3709000
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
19544000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.020
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.008
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.017
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.049
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.042
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.036
CY2022 pahc Effective Income Tax Rate Reconciliation Change In Unrecognized Tax Benefits Percent
EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsPercent
0.044
CY2021 pahc Effective Income Tax Rate Reconciliation Change In Unrecognized Tax Benefits Percent
EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsPercent
-0.068
CY2020 pahc Effective Income Tax Rate Reconciliation Change In Unrecognized Tax Benefits Percent
EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsPercent
0.052
CY2022 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
0.003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
0.013
CY2020 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
0.062
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.009
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.021
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.009
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.014
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.005
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.036
CY2022 us-gaap Effective Income Tax Rate Reconciliation Fdii Percent
EffectiveIncomeTaxRateReconciliationFdiiPercent
0.021
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.038
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.008
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.320
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.182
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.396
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
6879000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
6337000
CY2022Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
2288000
CY2021Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
2094000
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
751000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
765000
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1323000
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1522000
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
4348000
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
5517000
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
25510000
CY2022Q2 pahc Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
7187000
CY2021Q2 pahc Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
7550000
CY2022Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
7489000
CY2021Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
8251000
CY2022Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
24000
CY2021Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
793000
CY2022Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
14700000
CY2021Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
16594000
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4844000
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
8916000
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5849000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9861000
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1005000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
945000
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4844000
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
8916000
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3709000
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3403000
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
808000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-1091000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
306000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2595000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2618000
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3709000
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3403000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5311000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9507000
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6343000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
5333000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1873000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2850000
CY2022 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-1175000
CY2021 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-5354000
CY2020 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
108000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1071000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1109000
CY2022 pahc Unrecognized Tax Benefits Increase Decrease Resulting From Foreign Currency Translation
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromForeignCurrencyTranslation
-566000
CY2021 pahc Unrecognized Tax Benefits Increase Decrease Resulting From Foreign Currency Translation
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromForeignCurrencyTranslation
394000
CY2020 pahc Unrecognized Tax Benefits Increase Decrease Resulting From Foreign Currency Translation
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromForeignCurrencyTranslation
206000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7832000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5311000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9507000
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
427000
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
391000
CY2020Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
969000
CY2022Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
8259000
CY2021Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
5702000
CY2020Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
10476000
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
74000
CY2021 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
69000
CY2020 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
214000
CY2022 pahc Number Of Potentially Responsible Parties
NumberOfPotentiallyResponsibleParties
140
CY2022Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
4287000
CY2021Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
4293000
CY2022 pahc Employment Agreements Certain Executive Management And Other Employees Severance Benefits Term High End Of Range
EmploymentAgreementsCertainExecutiveManagementAndOtherEmployeesSeveranceBenefitsTermHighEndOfRange
P15M
CY2022Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
7900000
CY2022Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance On First Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
3800000
CY2022Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary
2200000
CY2022Q2 pahc Unrecorded Unconditional Purchase Obligation To Be Paid After Year Two
UnrecordedUnconditionalPurchaseObligationToBePaidAfterYearTwo
1900000
CY2022 pahc Acquisition Related Cost Of Goods Sold
AcquisitionRelatedCostOfGoodsSold
316000
CY2020 pahc Acquisition Related Cost Of Goods Sold
AcquisitionRelatedCostOfGoodsSold
280000
CY2022 pahc Acquisition Related Transaction Costs
AcquisitionRelatedTransactionCosts
279000
CY2020 pahc Acquisition Related Transaction Costs
AcquisitionRelatedTransactionCosts
462000
CY2020 pahc Acquisition Related Other
AcquisitionRelatedOther
-2821000
CY2020 us-gaap Restructuring Charges
RestructuringCharges
425000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1129000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2259000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
656861000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
561973000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-11875000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12880000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
0
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
942261000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
833350000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
800354000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
72327000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66468000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
55512000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-11875000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12880000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12856000
CY2022 pahc Corporate Costs
CorporateCosts
45767000
CY2021 pahc Corporate Costs
CorporateCosts
42624000
CY2020 pahc Corporate Costs
CorporateCosts
40178000
CY2022 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1203000
CY2022Q2 us-gaap Assets
Assets
931699000
CY2021Q2 us-gaap Assets
Assets
841325000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
165490000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
154706000

Files In Submission

Name View Source Status
0001558370-22-013940-index-headers.html Edgar Link pending
0001558370-22-013940-index.html Edgar Link pending
0001558370-22-013940.txt Edgar Link pending
0001558370-22-013940-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pahc-20220630.xsd Edgar Link pending
pahc-20220630x10k.htm Edgar Link pending
pahc-20220630x10k009.jpg Edgar Link pending
pahc-20220630xex21d1.htm Edgar Link pending
pahc-20220630xex23d1.htm Edgar Link pending
pahc-20220630xex31d1.htm Edgar Link pending
pahc-20220630xex31d2.htm Edgar Link pending
pahc-20220630xex32d1.htm Edgar Link pending
pahc-20220630xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
pahc-20220630_def.xml Edgar Link unprocessable
pahc-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pahc-20220630_pre.xml Edgar Link unprocessable
pahc-20220630x10k_htm.xml Edgar Link completed
R127.htm Edgar Link pending
R128.htm Edgar Link pending
R129.htm Edgar Link pending
R13.htm Edgar Link pending
R130.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pahc-20220630_cal.xml Edgar Link unprocessable